If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

  • This share is currently suspended. It was suspended at a price of 37.50
  • There is currently no data for CAT

Issue of Equity - Correction

29 Nov 2017 16:40

RNS Number : 8982X
CATCo Reinsurance Opps Fund Ltd
29 November 2017
 

THIS RELEASE REPLACES NO. 7652X WHICH WAS ANNOUNCED YESTERDAY.

The number of Ordinary shares was incorrectly reported.

All other details remain unchanged.

 

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL OR TO U.S. PERSONS.

 

CATCo Reinsurance Opportunities Fund Ltd.

 

Result of Equity Issue

 

To: Specialist Fund Segment, London Stock Exchange and Bermuda Stock Exchange

Date: 28 November 2017

 

Following its announcement on 8 November 2017, the Company is pleased to announce that it has received applications and commitments for a total of 543,000,000 new C Shares pursuant to the Initial Placing and Offer at the price of US$1 per share, raising gross proceeds of US$543,000,000. Accordingly applications under the Offer and commitments under the Initial Placing will all be met in full. The Company received commitments for a total of 528,845,098 C Shares through the Initial Placing and applications for a total of 14,154,902 C Shares through the Offer.

 

Application has been made for 543,000,000 C Shares to be issued pursuant to the Initial Placing and Offer to be admitted to trading on the Specialist Fund Segment of the London Stock Exchange. It is expected that Admission will become effective, and dealings will commence, at 8:00am (London time) on 1 December 2017.

 

Following Admission, the number of Ordinary Shares that the Company has in issue will be 391,666,430 and the number of C Shares that the Company has in issue will be 543,000,000. The C Shares carry the right to attend or vote at any general meeting of the Company in the same manner as the Ordinary Shares. Accordingly, the total number of voting rights in the Company will be 934,666,430 and the figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

 

The Company will instruct Euroclear on or around 1 December 2017 (or as soon as practicable thereafter) to credit the appropriate stock accounts in CREST of the placees and subscribers (on a delivery versus payment basis) with their respective entitlements to Depositary Interests in respect of C Shares. Temporary documents of title will not be issued pending the dispatch by post of definitive certificates for C Shares in certificated form, which is expected to take place in the week commencing 11 December 2017.

 

Tony Belisle, Chief Executive, Markel CATCo Investment Management Ltd., said:

 

"We are delighted with the tremendous support shown by existing and new investors for Markel CATCo's specialised ILS investment opportunity. The fundraise will ensure the Company continues to meet the growing demand from our buyers for our unique reinsurance protections."

 

For further information, please contact:

 

Judith Wynne, General Counsel

Mobile: +44 (0) 7986 205364

Telephone: +1 (441) 493 9005

Email: judith.wynne@markelcatco.com

 

Mark Way, Chief Operating Officer

Mobile: +1 (441) 504 9178

Telephone: +1 (441) 493 900

Email: mark.way@markelcatco.com

  

Numis Securities Limited

Hugh Jonathan / Harry Trueman

Telephone: +44 (0) 20 7260 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEPGGAWGUPMGQB
Date   Source Headline
12th Oct 201712:44 pmRNSHolding(s) in Company
4th Oct 20172:00 pmRNSAGM Statement
2nd Oct 20177:00 amRNSIssue of Equity and Portfolio Update
21st Sep 20177:00 amRNSNet Asset Value(s)
29th Aug 201712:49 pmRNSStatement re Hurricane Harvey
18th Aug 20177:00 amRNSHalf-year Report
17th Aug 201711:54 amRNSHolding(s) in Company
17th Aug 20177:00 amRNSNet Asset Value(s)
20th Jul 20177:00 amRNSNet Asset Value(s)
21st Jun 20177:00 amRNSInvestment Manager - Executive Update
19th Jun 20177:00 amRNSNet Asset Value(s)
5th Jun 20173:20 pmRNSHolding(s) in Company
1st Jun 20176:25 pmRNSHolding(s) in Company
1st Jun 20174:43 pmRNSHolding(s) in Company
25th May 20175:14 pmRNSHolding(s) in Company
25th May 20172:51 pmRNSIssue of Equity
16th May 20177:00 amRNSNet Asset Value(s) and Issuance of Shares
15th May 20177:00 amRNSProposed Capital Raise
11th May 20178:00 amRNSConversion of Securities
19th Apr 20177:00 amRNSNet Asset Value(s)
6th Apr 20172:00 pmRNSAGM Statement
30th Mar 20172:25 pmRNSDirector/PDMR Shareholding
21st Mar 20174:48 pmRNSHolding(s) in Company
16th Mar 201711:33 amRNSNet Asset Value(s)
2nd Mar 20177:00 amRNSDirectorate Change
2nd Mar 20177:00 amRNSAnnual Financial Report
27th Feb 20177:00 amRNSNet Asset Value(s)
31st Jan 20177:00 amRNSPortfolio Update
26th Jan 20171:17 pmRNSDividend Declaration
20th Jan 20177:00 amRNSNet Asset Value and Portfolio Update
19th Dec 20167:00 amRNSNet Asset Value(s)
18th Nov 20167:00 amRNSTender Offer
14th Nov 20167:00 amRNSNet Asset Value(s)
8th Nov 20165:27 pmRNSHolding(s) in Company
20th Oct 20161:51 pmRNSHolding(s) in Company
19th Oct 20167:00 amRNSNet Asset Value(s)
19th Sep 20167:00 amRNSNet Asset Value and Portfolio Update
22nd Aug 20167:00 amRNSNet Asset Value(s)
15th Aug 20167:00 amRNSDirector/PDMR Shareholding
12th Aug 20167:00 amRNSHalf-year Report
19th Jul 20167:00 amRNSNet Asset Value(s)
17th Jun 20163:58 pmRNSNet Asset Value(s)
16th May 201612:57 pmRNSNet Asset Value(s)
10th May 20167:00 amRNSDirectorate Change
19th Apr 20167:00 amRNSNet Asset Value(s)
24th Mar 20165:35 pmRNSIssue of Equity
22nd Mar 201612:46 pmRNSResult of AGM
18th Mar 20167:00 amRNSNet Asset Value(s)
14th Mar 20161:18 pmRNSHolding(s) in Company
7th Mar 20167:00 amRNSSide-Pocket Investment Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.